Trial Type: Pancreas

LS-P-CAPE
A Phase II, Open-label, Multi-centre Study to Evaluate Safety, Tolerability, Efficacy, PK, and Immunogenicity of AZD0901 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Tumours Expressing Claudin 18.2 (CLARITY-PanTumour01)
Protocol Status: OPEN TO ACCRUAL
Trial Type: Esophagus, Gastrointestinal, Other Digestive Organ, Pancreas, Stomach
Contact: Raufi, Alexander
araufi2@BrownHealth.org
BH-P-ENACT
A Phase 2 Study to Investigate the Efficacy and Safety of Acoustic Cluster Therapy With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer
Protocol Status: OPEN TO ACCRUAL
Trial Type: Gastrointestinal, Pancreas
Contact: Raufi, Alexander
araufi2@BrownHealth.org
LS-P-GO44479
A Phase II, Open-Label, Multicenter, Randomized Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Patients With Resected Pancreatic Ductal Adenocarcinoma
Protocol Status: OPEN TO ACCRUAL
Trial Type: Gastrointestinal, Pancreas
Contact: Raufi, Alexander
araufi2@BrownHealth.org
NRG-GI011
A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)
Protocol Status: OPEN TO ACCRUAL
Trial Type: Gastrointestinal, Pancreas
Contact: Rogers, Sherise
srogers102@brownhealth.org
BH-P-SPARK
A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of ASP3082 in Combination With mFOLFIRINOX or NALIRIFOX as First-line Treatment in Participants With KRAS G12D Mutated Metastatic Pancreatic Adenocarcinoma
Protocol Status: OPEN TO ACCRUAL
Trial Type: Gastrointestinal, Pancreas
Contact: Raufi, Alexander
araufi2@BrownHealth.org